CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 60 filers reported holding CTI BIOPHARMA CORP in Q2 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $202,973 | -28.7% | 48,327 | +2.0% | 0.00% | -50.0% |
| Q4 2022 | $284,664 | +2.8% | 47,365 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $277,000 | +6.9% | 47,537 | +9.7% | 0.00% | 0.0% |
| Q2 2022 | $259,000 | +709.4% | 43,353 | +33.1% | 0.00% | – |
| Q1 2019 | $32,000 | +28.0% | 32,574 | -3.1% | 0.00% | – |
| Q4 2018 | $25,000 | -65.8% | 33,631 | -0.8% | 0.00% | – |
| Q3 2018 | $73,000 | -56.0% | 33,889 | +1.8% | 0.00% | -100.0% |
| Q2 2018 | $166,000 | – | 33,278 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 4,684,404 | $21,876,000 | 9.07% |
| Lion Point Capital, LP | 5,489,546 | $25,636,000 | 5.95% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2,250,000 | $10,508,000 | 4.35% |
| Bleichroeder LP | 3,859,707 | $18,025,000 | 3.20% |
| NEA Management Company, LLC | 7,140,450 | $99,804,000 | 2.88% |
| BVF INC/IL | 8,929,690 | $41,702,000 | 1.67% |
| Ghost Tree Capital, LLC | 1,300,000 | $6,071,000 | 1.32% |
| EAM Investors, LLC | 1,011,935 | $4,726,000 | 0.88% |
| Knott David M Jr | 556,687 | $2,600,000 | 0.83% |
| Sofinnova Investments, Inc. | 1,952,691 | $9,119,000 | 0.69% |